Trial
NCT00719849
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Leukemia
Intervention
anti-thymocyte globulin
Why stopped
A new protocol was developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-14